Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.

Although a reduced expression of nm23 has been shown to correlate with a high metastatic potential in some human cancers, in colorectal cancers, conflicting data have been reported. As there are two homologous genes, nm23-H1 and nm23-H2, which encode the A and B subunits of nucleoside diphosphate kinase, efficient and simplified techniques were designed to selectively study nm23-H1 and -H2 expression in 35 colorectal cancers at both the protein and mRNA levels by immunoblotting, immunohistochemistry, and reverse transcription polymerase chain reaction (RT PCR) using specific antibodies and primers. Nm23-H1 and Nm23-H2 proteins were overexpressed in tumours compared with adjacent mucosa. This overexpression was lost, however, in some advanced cases: 89% and 81% of TNM (tumour, node, metastases) stages 0-II showed Nm23-H1 and -H2 overexpression, respectively, which significantly differed from 47% and 38% of stage III-IV tumours. Similar results were seen with nm23-H1 mRNA. Heterogenous labelling of tumoral cells was seen by immunohistological staining. This suggests a dichotomy: an overexpression of nm23-H1 and -H2 linked to early stages of cancer and a loss of nm23-H1 overexpression seen in more advanced stages. Therefore specific nm23-H1 determination should be evaluated as a prognostic factor in human colorectal carcinoma.

[1]  S. Banerjee,et al.  Mutation in the nm23 gene is associated with metastasis in colorectal cancer. , 1993, Cancer research.

[2]  L. Liotta,et al.  Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development , 1989, Nature.

[3]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[4]  J. Strahler,et al.  High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. , 1991, The Journal of clinical investigation.

[5]  S. Nagataki,et al.  Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. , 1992, Journal of the National Cancer Institute.

[6]  R. Eddy,et al.  Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. , 1993, Oncogene.

[7]  F. Bertrand,et al.  Phosphorylation of vimentin is an intermediate step in protein kinase C-mediated glycoconjugate secretion. , 1994, The American journal of physiology.

[8]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[9]  J. Arends,et al.  A multivariate analysis of pathologic prognostic indicators in large bowel cancer , 1988, Cancer.

[10]  S. J. Flint,et al.  Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. , 1993, Science.

[11]  T. Urano,et al.  Isolation of human nm23 genomes and analysis of loss of heterozygosity in primary colorectal carcinomas using a specific genomic probe. , 1994, Cancer research.

[12]  S. Hanash,et al.  nm23-H1 mutation in neuroblastoma , 1994, Nature.

[13]  A. Gilles,et al.  Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. , 1991, The Journal of biological chemistry.

[14]  T. Urano,et al.  Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. , 1993, British Journal of Cancer.

[15]  F. Bosch,et al.  Prognostic significance of the loss of heterozygosity of nm23‐h1 and p53 genes in human colorectal carcinomas , 1994, Cancer.

[16]  J. Overmeyer,et al.  Prevalence of nucleoside diphosphate kinase autophosphorylation in human colon carcinoma versus normal colon homogenates , 1989, Molecular carcinogenesis.

[17]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[18]  K. Jakobs,et al.  Nucleoside diphosphate kinases as potential new targets for control of development and cancer. , 1992, Trends in pharmacological sciences.

[19]  L. Liotta,et al.  Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. , 1991, The American journal of pathology.

[20]  L. Myeroff,et al.  Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. , 1993, Journal of the National Cancer Institute.

[21]  L. Liotta,et al.  Somatic allelic deletion of nm23 in human cancer. , 1991, Cancer research.

[22]  H. Yokozaki,et al.  Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[23]  P. Steeg,et al.  H 2 Gene , nm 23 Identification of a Second Human Updated , 2006 .

[24]  S. Dooley,et al.  High levels of NM23‐H1 and NM23‐H2 messenger RNA in human squamous‐cell lung carcinoma are associated with poor differentiation and advanced tumor stages , 1993, International journal of cancer.

[25]  K. Hirokawa,et al.  Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer. , 1991, Journal of the National Cancer Institute.

[26]  T. Urano,et al.  Expression of human nm23‐H1 and nm23‐H2 proteins in hepatocellular carcinoma , 1994, Cancer.

[27]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[28]  H. Ohigashi,et al.  Clinicopathological features and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic exocrine neoplasms , 1993, International journal of pancreatology : official journal of the International Association of Pancreatology.

[29]  L. Eldik,et al.  Conditions for reproducible detection of calmodulin and S100β in immunoblots , 1984 .

[30]  G. Taylor,et al.  Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. , 1993, Gastroenterology.

[31]  J. Thiery,et al.  Overexpression of nucleoside diphosphate kinase (Nm23) in solid tumours. , 1991, European journal of cancer.

[32]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[33]  S. Cross,et al.  Nm23 ‘anti‐metastatic’ gene product expression in colorectal carcinoma , 1994, The Journal of pathology.

[34]  P. Steeg,et al.  A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. , 1993, The Journal of biological chemistry.

[35]  P. Steeg,et al.  Inhibition of cell motility after nm23 transfection of human and murine tumor cells. , 1993, Cancer research.

[36]  O. Myklebost,et al.  Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. , 1992, Cancer research.

[37]  P. Steeg,et al.  Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma , 1991, The Lancet.

[38]  徳永祐二.  REDUCED EXPRESSION OF nm23-H1,BUT NOT OF nm23-H2,IS CONCORDANT WITH THE FREQUENCY OF LYMPH-NODE METASTASIS OF HUMAN BREAST CANCER , 1996 .

[39]  B. Weissman,et al.  Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. , 1994, Oncogene.

[40]  O. Delattre,et al.  Survival and acquired genetic alterations in colorectal cancer. , 1992, Gastroenterology.

[41]  H. Magdelenat,et al.  Nucleoside diphosphate kinase/NM23 expression in breast cancer: Lack of correlation with lymph‐node metastasis , 1992, International journal of cancer.

[42]  L. Liotta,et al.  Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. , 1989, Cancer research.

[43]  H. Tashiro,et al.  Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. , 1994, Cancer research.

[44]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[45]  P. Steeg,et al.  Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. , 1993, Oncogene.

[46]  J. Willson,et al.  Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. , 1991, Journal of the National Cancer Institute.

[47]  J. Northover,et al.  The Nm23 gene and colorectal cancer. , 1994, Gut.

[48]  Y. Kodera,et al.  Expression of nm23 H‐1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis , 1994, Cancer.

[49]  M. Watanabe,et al.  Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid. , 1993, The American journal of pathology.